Branded Generics^TM
New Avenue for RX Expansion into
Emerging Markets

With patents expiring shortly on numerous branded prescriptions, pharmaceutical manufacturers are expected to lose up to $180 billion in the U.S. in sales to generics over the next five years. But a type of generic drug, if positioned carefully to the right market, could offer a new way for pharmaceutical manufacturers to actually broaden their sales.

Called "branded generics", they are generic drugs that carry a big pharma name and are gaining increasing popularity in emerging markets-especially China, India, and Latin America. Generic drugs already represent 25 percent on average of worldwide pharmaceuticals sales. Thanks to these markets, branded generics are likely to reach up to 75 percent of sales growth within the next 10 years.

That's because overseas consumers respect and trust branded drugs more than local generics. Consumers perceive the latter as being satisfied with lax quality controls, while branded drugs are trusted to have a higher level of quality and effectiveness.

With the tremendous growth in sales in emerging markets expected over the next 10 years, now is the time to join the BRANDED GENERICS conference to find out whether this opportunity for sales expansion is right for you.

You will meet face-to-face with hundreds of pharmaceutical and generic manufacturers from the U.S. and overseas, and walk away with valuable insights and contacts for your next campaign!

Barrie, Ontario - February, 17 2012 - New Pharma Magazine, the first interactive publication of its kind in the pharma industry, is holding its launch party in NYC!

The pre-eminent source of news, events, and lifestyle for decision makers in the pharmaceutical industry, will be making a splash with its launch party during DCAT week. The event is to take place on March 14th, 2012 at 8:30 p.m in the Heart Beat Restaurant of The W Hotel, New York and will cater to an exclusive guest list.

Pharma superstars such as Ed Borkowski, former CFO of Mylan will be in attendance, along with former colleague Stu Williams (General Counsel). They will be joined by the president of Generic Pharma 2.0 and other industry 'must meets'.
The evening will consist of cocktails and petit fours, as well as a host of door prizes. DCAT Week, is also supporting the magazine through member lounge distribution and various other promotions.

About New Pharma Magazine:

New Pharma is a pharmaceutical magazine like no other, with exclusive content specializing in generics, otc, biosimilar & animal health. Key topics include strategy, marketing, technology, business culture, law & emerging markets. New Pharma Magazine is not a science journal and is focused on engaging readers on a corporate level, in terms of strategy and direction of the industry over all.

"New Pharma is an exciting new publication that reflects the need for strategic thinking in a changing industry" - Ed Borkowski, former CFO Mylan

New Pharma Magazine has invited those interested in attending to fill out a guest list application @ www.newpharmamag.com/launchparty! Don't miss out on the first of many great events, brought to you by New Pharma Magazine!

Asia's largest bio event, consisting of Partnering, Conference (total 350* sessions) and Exhibition (650* exhibitors). (*expected)

25th INTERPHEX JAPAN is World's leading pharmaceutical event, gathering 1450* exhibitors and 62,000* visitors. (*expected)

Covering the whole pharmaceutical process from R&D to manufacturing, it is evaluated as the one and only B to B platform where the Japanese & Asian pharmaceutical industry gather under one roof.